Compare SNN & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNN | XPEV |
|---|---|---|
| Founded | 1856 | 2015 |
| Country | United Kingdom | China |
| Employees | 16988 | 19884 |
| Industry | Industrial Specialties | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 17.1B |
| IPO Year | N/A | N/A |
| Metric | SNN | XPEV |
|---|---|---|
| Price | $31.88 | $15.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $36.25 | $23.08 |
| AVG Volume (30 Days) | 828.2K | ★ 4.6M |
| Earning Date | 03-16-2026 | 05-20-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.58 | $25.76 |
| Revenue Next Year | $5.60 | $25.98 |
| P/E Ratio | $64.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.33 | $15.38 |
| 52 Week High | $38.79 | $28.20 |
| Indicator | SNN | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 34.73 |
| Support Level | $29.27 | $15.38 |
| Resistance Level | $32.22 | $18.38 |
| Average True Range (ATR) | 0.60 | 0.47 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 10.88 | 6.44 |
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.